Reimbursement for the CELLSEARCH® Circulating Tumor Cell Test is available through various public and private payers

Payer States Status/LCD ID* Coding
Cigna Government Services OH, KY Positive coverage
L 32301
86152; 86153
First Coast Service Options FL, USVI, PR Positive coverage
L 32096
L 32098
86152; 86153
Cahaba Government Services TN, AL, GA Positive coverage
L 32293
86152; 86153
Wisconsin Physician Services IA, IN, KS, MI, MO, NE Positive coverage
L 32218
86152; 86153
Noridian AK, AZ, ID, MT, ND, OR, SD, UT, WA, WY Non Coverage
L 32528
86152; 86153
Noridian CA, HI, NV Non Coverage
L 35217
86152; 86153
Palmetto GBA NC, SC, VA, WV Non Coverage
L 34631
86152; 86153
Z code: ZBD69
Novitas AR, CO, DE, DC, LA, MD, MS, NJ, OK, PA, TX Retired Coverage Policy
L 32930
L 33232
86152; 86153
National Government Services CT,IL,ME,MA,MN,NH,NY,RI,VT,WI Non Coverage
L 32965
86152; 86153
United HealthCare National Commercial Positive Coverage 86152; 86153

NOTE: Providers should check with their carriers and payers to determine appropriate coding and billing procedures which may be subject to change; check with your carrier/payer for any questions regarding coverage.

86152 Cell enumeration using immunologic selection and identification in fluid specimen (eg, circulating tumor cells in blood).

86153 Interpretation of results.

The information provided represents no statement, promise, or guarantee by Janssen Diagnostics concerning coverage, levels of reimbursement, payment or changes. Please consult your payer organization with regard to local or actual coverage and reimbursement policies and determination processes.

*Please note: All local coverage decision policies are available online at

View PDF 2016 Medicare Clinical Laboratory Fee Schedule